-
Live preview uses customized excipients to meet new challenges in formulations
Time of Update: 2022-04-16
Thursday, February 24 14:00 - 15:00 IFF Pharmaceutical Solutions Dr.
Gao Hao , an application technology expert in the Asia-Pacific region will discuss with you
-
Hu Shanlian: Frontier Tracking of the Cost-effectiveness of New Crown Oral Drugs
Time of Update: 2022-04-16
The results of the phase III clinical trial were: the hospitalization and mortality rate of the treatment group was 7.
-
What is the speed of the listing application review?
Time of Update: 2022-04-16
On the whole, from the time when the marketing application "entered the CDE review center" to the "certificate preparation - approval has been issued", the shortest review and approval process was CStone's pratinib capsules, which only took 198 days .
-
The fifty-seventh batch of reference preparations for chemical generic drugs (draft for comments) was released
Time of Update: 2022-04-16
25, 2019) issued by the National Bureau on March 28, 2019, the center organized the selection of The fifty-seventh batch of reference preparations is now publicized for comments .
docx 2 Chemical Generic Drug Reference Preparation Objection Application Form.
-
The State Food and Drug Administration has approved 12 new coronavirus antigen detection reagents
Time of Update: 2022-04-16
On March 15, after review by the State Food and Drug Administration, two new coronavirus antigen detection reagent products were approved .
As of March 16, the State Food and Drug Administration has approved 12 new coronavirus antigen detection reagent products .
-
Brief description of new drug types, FIC/BIC/Me-too/Me-copy are silly and unclear
Time of Update: 2022-04-16
Different from foreign Me-too drugs, China's new Me-copy drugs are not optimized through high-throughput screening, starting from HITs, but with known active structures at the same target.
-
Baiyunshan's cash flow has increased by 9 times, and the joint mining price of the eight provinces has been cut by more than 90%.
Time of Update: 2022-04-16
(National Medical Insurance Administration) Market tide Unnamed medicine faces the risk of termination of listing On March 21, the Shenzhen Stock Exchange issued a letter of concern about Shandong Weiming Biology.
-
New regulations for the production and operation of medical devices have been introduced!
Time of Update: 2022-04-16
Strengthen the control of quality and safety risks, clarify the key points of production and operation supervision and inspection, and clarify the quality responsibilities and management requirements for the provision of transportation and storage services for medical device registrants, filers, and operating enterprises .
-
PHEXCOM VIP member unit IMCD is looking for sales managers!
Time of Update: 2022-04-16
Job Title: Sales ManagerSales Manager Responsibilities: 1.
Responsible for the promotion of pharmaceutical excipient products and create more business opportunities 2.
Develop and update sales forecasts in a timely manner, as well as the collection of accounts receivable 5.
Strong communication skills and business development skills 4.
-
PhExTour Jinan Station Postponed
Time of Update: 2022-04-16
In order to strictly prevent the spread of the epidemic, the "PHEXTOUR Pharmaceutical Preparation Technology Tour Seminar" originally scheduled to be held in Jinan on March 16-17 will be postponed until further notice .
-
Exclusive writer: Blood products with scarce raw materials are first collected!
Time of Update: 2022-04-16
Judging from the list published in the report list, the intravenous injection of human immunoglobulin (pH4) and human immunoglobulin centralized collection involves nearly 30 companies, including Shanghai RAAS Blood Products, Hualan Bioengineering Chongqing, Shandong Taibang Biological products, Sichuan Yuanda Shuyang Pharmaceutical Co.
-
210 million yuan to introduce!
Time of Update: 2022-04-16
In China, a total of 4 long-acting Baiyao products have been approved for marketing, including Jinyouli from CSPC , Xinruibai from Qilu Pharmaceutical, Aido (19K for short) from Hengrui Medicine, and recombinant human granulocytes from Shandong New Era.
-
Heavy!
Time of Update: 2022-04-16
[2] "Chronic kidney disease kills 5 to 10 million people worldwide each year, and the lives of many patients are severely impacted by frequent dialysis treatments," said Associate Professor William Herrington, University of Oxford Population Health Clinical Scientist, Honorary Consultant in Nephrology, and EMPA-KIDNEY Co-Principal Investigator .
-
Clinical trials of multiple drugs have made new progress!
Time of Update: 2022-04-15
Sino Biopharma recently announced that the Group's self-developed Class I anti-tumor innovative drug "FHND5071" has been approved for clinical trials for the treatment of advanced solid tumors .
-
The gospel of over 15 million atrial fibrillation patients!
Time of Update: 2022-04-15
Recently, there is good news that Sanofi's new anti-arrhythmic drug, Midarone Dronedarone Hydrochloride Tablets, has been launched in China for sinus rhythm patients with a history of paroxysmal or persistent atrial fibrillation (AF).
-
One million yuan a shot of CAR-T cell therapy products, or fight for medical insurance!
Time of Update: 2022-04-15
In addition, Fosun Pharma stated that the technology transfer of the second CAR-T product has been completed within the reporting period, and the clinical trial application for relapsed or refractory mantle cell lymphoma was approved for clinical trials by the State Food and Drug Administration in March 2022.
-
Since the beginning of this year, a large number of drugs have been suspended from trading!
Time of Update: 2022-04-15
[Pharmaceutical Network Industry News] Recently, the Inner Mongolia Autonomous Region Pharmaceutical Purchasing Center issued the "Notice on Suspension of Qualifications for Drug Transactions such as Weikangling Capsules" .
-
The use of artificial intelligence to develop new treatments has become a trend in the industry
Time of Update: 2022-04-15
[Pharmaceutical Network Industry News] With the rise of a new generation of information technology and the development of many high-tech fields, a series of cutting-edge technologies represented by artificial intelligence have begun to shine in various traditional fields.
-
Another domestic HPV vaccine is about to be approved!
Time of Update: 2022-04-15
[Pharmaceutical Network Industry News] Recently, the website of the Food and Drug Administration showed that the marketing application of the recombinant human papillomavirus bivalent (16/18 type) vaccine (yeast) of a subsidiary of Watson Bio (acceptance numbers: CXSS2000024, CXSS2000025, pre-filled The two dosage forms of syringe and vial) have entered the stage of "administrative approval" and are expected to be launched soon .
-
4 more injection varieties passed the consistency evaluation!
Time of Update: 2022-04-15
[Pharmaceutical Network Industry News] Recently, on March 24, 2022, the drug approval certificate pending information release, a total of 17 varieties have passed/deemed to pass the consistency of generic drugs, of which 4 varieties are injections/injectable drugs, including injection Cefoperazone Sodium Sulbactam Sodium (Lijian Pharmaceutical), Arginine Glutamate Injection (Haisco), Cefepime Hydrochloride for Injection (Xinfeng Pharmaceutical), Gadobutrol Injection (Hengrui Pharmaceutical), and There are 2 varieties that have been reviewed by the head home .
